SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000935836-21-000181
Filing Date
2021-02-18
Accepted
2021-02-17 20:14:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 prothena13da.htm SC 13D/A 52864
  Complete submission text file 0000935836-21-000181.txt   54610
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Subject) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87112 | Film No.: 21647180
SIC: 2834 Pharmaceutical Preparations

Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103 415-448-6534
EcoR1 Capital Fund, L.P. (Filed by) CIK: 0001567938 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A